StemCell Institute Inc. (TYO:7096)

StemCell Institute Revenue

In the fiscal year ending March 31, 2026, StemCell Institute had annual revenue of 2.81B JPY with 4.93% growth. StemCell Institute had revenue of 667.00M in the quarter ending March 31, 2026, with 4.38% growth.

• Revenue: 2.81B
• Revenue Growth: +4.93%
• P/S Ratio: 2.43
• Revenue / Employee: 24.03M
• Employees: 117
• Market Cap: 6.83B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	2.81B	132.00M	4.93%
Mar 31, 2025	2.68B	198.00M	7.98%
Mar 31, 2024	2.48B	390.00M	18.65%
Mar 31, 2023	2.09B	310.00M	17.41%
Mar 31, 2022	1.78B	372.00M	26.40%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 29, 2026

Data Sources Report a data error